New target prediction and visualization tools incorporating open source molecular fingerprints for TB Mobile 2.0
- PMID: 25302078
- PMCID: PMC4190048
- DOI: 10.1186/s13321-014-0038-2
New target prediction and visualization tools incorporating open source molecular fingerprints for TB Mobile 2.0
Abstract
Background: We recently developed a freely available mobile app (TB Mobile) for both iOS and Android platforms that displays Mycobacterium tuberculosis (Mtb) active molecule structures and their targets with links to associated data. The app was developed to make target information available to as large an audience as possible.
Results: We now report a major update of the iOS version of the app. This includes enhancements that use an implementation of ECFP_6 fingerprints that we have made open source. Using these fingerprints, the user can propose compounds with possible anti-TB activity, and view the compounds within a cluster landscape. Proposed compounds can also be compared to existing target data, using a näive Bayesian scoring system to rank probable targets. We have curated an additional 60 new compounds and their targets for Mtb and added these to the original set of 745 compounds. We have also curated 20 further compounds (many without targets in TB Mobile) to evaluate this version of the app with 805 compounds and associated targets.
Conclusions: TB Mobile can now manage a small collection of compounds that can be imported from external sources, or exported by various means such as email or app-to-app inter-process communication. This means that TB Mobile can be used as a node within a growing ecosystem of mobile apps for cheminformatics. It can also cluster compounds and use internal algorithms to help identify potential targets based on molecular similarity. TB Mobile represents a valuable dataset, data-visualization aid and target prediction tool.
Keywords: Mobile app; Mycobacterium tuberculosis; TB mobile; Target prediction; Tuberculosis.
Figures






Similar articles
-
Smartphone Applications to Support Tuberculosis Prevention and Treatment: Review and Evaluation.JMIR Mhealth Uhealth. 2016 May 13;4(2):e25. doi: 10.2196/mhealth.5022. JMIR Mhealth Uhealth. 2016. PMID: 27177591 Free PMC article. Review.
-
TB Mobile: a mobile app for anti-tuberculosis molecules with known targets.J Cheminform. 2013 Mar 6;5(1):13. doi: 10.1186/1758-2946-5-13. J Cheminform. 2013. PMID: 23497706 Free PMC article.
-
Medication Management Apps for Diabetes: Systematic Assessment of the Transparency and Reliability of Health Information Dissemination.JMIR Mhealth Uhealth. 2020 Feb 19;8(2):e15364. doi: 10.2196/15364. JMIR Mhealth Uhealth. 2020. PMID: 32130163 Free PMC article.
-
Machine Learning Models for Mycobacterium tuberculosisIn Vitro Activity: Prediction and Target Visualization.Mol Pharm. 2022 Feb 7;19(2):674-689. doi: 10.1021/acs.molpharmaceut.1c00791. Epub 2021 Dec 29. Mol Pharm. 2022. PMID: 34964633 Free PMC article.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
Cited by
-
Smartphone Applications to Support Tuberculosis Prevention and Treatment: Review and Evaluation.JMIR Mhealth Uhealth. 2016 May 13;4(2):e25. doi: 10.2196/mhealth.5022. JMIR Mhealth Uhealth. 2016. PMID: 27177591 Free PMC article. Review.
-
The Next Era: Deep Learning in Pharmaceutical Research.Pharm Res. 2016 Nov;33(11):2594-603. doi: 10.1007/s11095-016-2029-7. Epub 2016 Sep 6. Pharm Res. 2016. PMID: 27599991 Free PMC article. Review.
-
The polypharmacology browser: a web-based multi-fingerprint target prediction tool using ChEMBL bioactivity data.J Cheminform. 2017 Feb 21;9:11. doi: 10.1186/s13321-017-0199-x. eCollection 2017. J Cheminform. 2017. PMID: 28270862 Free PMC article.
-
Making Transporter Models for Drug-Drug Interaction Prediction Mobile.Drug Metab Dispos. 2015 Oct;43(10):1642-5. doi: 10.1124/dmd.115.064956. Epub 2015 Jul 21. Drug Metab Dispos. 2015. PMID: 26199424 Free PMC article.
-
Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery.PLoS Negl Trop Dis. 2015 Jun 26;9(6):e0003878. doi: 10.1371/journal.pntd.0003878. eCollection 2015. PLoS Negl Trop Dis. 2015. PMID: 26114876 Free PMC article.
References
-
- Macarron R, Banks MN, Bojanic D, Burns DJ, Cirovic DA, Garyantes T, Green DV, Hertzberg RP, Janzen WP, Paslay JW, Schopfer U, Sittampalam GS. Impact of high-throughput screening in biomedical research. Nat Rev Drug Discov. 2011;10:188–195. - PubMed
-
- Abdel-Rahman SM, Marcucci K, Boge T, Gotschall RR, Kearns GL, Leeder JS. Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafine. Drug Metab Dispos. 1999;27:770–775. - PubMed
-
- Balganesh TS, Alzari PM, Cole ST. Rising standards for tuberculosis drug development. Trends Pharmacol Sci. 2008;29:576–581. - PubMed
-
- http://www.who.int/tb/publications/global_report/en/ Global tuberculosis report 2013. [] - PubMed
-
- Zumla A, George A, Sharma V, Herbert N, Baroness Masham Of I. WHO’s 2013 global report on tuberculosis: successes, threats, and opportunities. Lancet. 2014;382:1765–1767. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources